The total value of China's pharmaceutical industry increased from 7.28 billion yuan in 1978 to 1.25 trillion yuan in 2010, an increase of 170 times in 32 years. At the 3rd China Annual Meeting of the Pharmaceutical Information Association recently held in Beijing, Shao Mingli, Deputy Minister of Health and Director of the State Food and Drug Administration pointed out that China's pharmaceutical industry has entered a golden period of development. During the “Twelfth Five-Year Plan” period, drug regulatory agencies, pharmaceutical companies, research institutions and other parties will strengthen collaboration to fully promote the transformation and development of the pharmaceutical industry and industrial restructuring.

Shao Mingli said that at present, China can produce more than 1,500 kinds of raw materials and more than 4,000 kinds of chemical preparations. The annual output of vaccines exceeds 1 billion dose units. It also has 13,000 pharmaceutical wholesale companies and 367,000 retail enterprises, and it has formed a complete set. Drug production and supply system. The investment of multinational corporations in China has continued to expand. According to statistics, in 2010, the actual amount of foreign capital used in the pharmaceutical industry in China reached 1.028 billion U.S. dollars, an increase of 83.61 million U.S. dollars over the same period of 2009.

The annual meeting was sponsored by the Drug Information Association and China Pharmaceutical International Exchange Center.